Clovis Oncology, Inc. Foreign Pre-Tax Income
Clovis Oncology, Inc. reported Foreign Pre-Tax Income of $650.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign · last filed 2022-02-24
- Clovis Oncology, Inc. income (loss) from continuing operations before income taxes, foreign for fiscal 2021 was $650.00K, a 39.81% decline from fiscal 2020.
- Clovis Oncology, Inc. income (loss) from continuing operations before income taxes, foreign for fiscal 2020 was $1.08M, a 24.00% increase from fiscal 2019.
- Clovis Oncology, Inc. income (loss) from continuing operations before income taxes, foreign for fiscal 2019 was $871.00K, a 12.99% decline from fiscal 2018.
- Clovis Oncology, Inc. income (loss) from continuing operations before income taxes, foreign for fiscal 2018 was $1.00M, a 26.56% decline from fiscal 2017.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Foreign 12 month |
|---|---|
| 2021-12-31 | $650.00K 10-K · filed 2022-02-24 |
| 2020-12-31 | $1.08M 10-K · filed 2022-02-24 |
| 2019-12-31 | $871.00K 10-K · filed 2022-02-24 |
| 2018-12-31 | $1.00M 10-K · filed 2021-02-25 |
| 2017-12-31 | $1.36M 10-K · filed 2020-02-26 |
| 2016-12-31 | -$103.39M 10-K · filed 2019-02-28 |
| 2015-12-31 | -$91.59M 10-K · filed 2018-02-27 |
| 2014-12-31 | $7.50M 10-K · filed 2017-02-23 |
| 2013-12-31 | $54.00K 10-K · filed 2016-02-29 |
| 2012-12-31 | $126.00K 10-K · filed 2015-02-27 |